Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 9/2015

01-09-2015 | Retraction Note

Retraction Note to: Common polymorphism in the MMP-13 gene may contribute to the risk of human cancers: a meta-analysis

Authors: Ping Gao, Jun-Lan Yang, Hong Zhao, Jun-Hao You, Yi Hu

Published in: Tumor Biology | Issue 9/2015

Login to get access

Excerpt

Retraction to: Tumor Biol. (2014) 35:10137–10148 …
Metadata
Title
Retraction Note to: Common polymorphism in the MMP-13 gene may contribute to the risk of human cancers: a meta-analysis
Authors
Ping Gao
Jun-Lan Yang
Hong Zhao
Jun-Hao You
Yi Hu
Publication date
01-09-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 9/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3785-4

Other articles of this Issue 9/2015

Tumor Biology 9/2015 Go to the issue

Research Article

Decreased expression of RPS15A suppresses proliferation of lung cancer cells

Research Article

Genetic polymorphisms of the multidrug resistance 1 gene MDR1 and the risk of hepatocellular carcinoma

Research Article

C-reactive protein inhibits expression of N-cadherin and ZEB-1 in murine colon adenocarcinoma

Commentary

Reply to: “in vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a meta-analysis”

Research Article

Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells

Research Article

A peptide derivative serves as a fibroblast growth factor 2 antagonist in human gastric cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits